| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Medline Inc.
13G/A
Amendment 2
MDLN · 58507V107
|
16.0% |
8/11/2026
Event 6/30/2026
|
|||
| Hellman & Friedman Capital Partners X (Parallel), L.P. | 6.4% | ||||
| HFCP X (Parallel - A), L.P. | 0.7% | ||||
| Mend Partners II, L.P. | 0.4% | ||||
| Mend Investment Holdings I, L.P. | 8.6% | ||||
| Hellman & Friedman Investors X, L.P. | 16.0% | ||||
| Mend Partners GP, LLC | 0.4% | ||||
| Mend Investment Holdings GP, LLC | 8.6% | ||||
| Hellman & Friedman Capital Partners X, L.P. | 8.6% | ||||
| H&F Corporate Investors X, Ltd. | 16.0% | ||||
|
Medline Inc.
13G/A
Amendment 1
MDLN · 58507V107
|
19.8% |
5/6/2026
Event 3/31/2026
|
|||
| Hellman & Friedman Capital Partners X (Parallel), L.P. | 7.9% | ||||
| HFCP X (Parallel - A), L.P. | 0.8% | ||||
| Mend Partners II, L.P. | 0.4% | ||||
| Mend Investment Holdings I, L.P. | 10.6% | ||||
| Hellman & Friedman Investors X, L.P. | 19.8% | ||||
| Mend Partners GP, LLC | 0.4% | ||||
| Mend Investment Holdings GP, LLC | 10.6% | ||||
| Hellman & Friedman Capital Partners X, L.P. | 10.6% | ||||
| H&F Corporate Investors X, Ltd. | 19.8% | ||||
|
Medline Inc.
13G
MDLN · 58507V107
|
23.2% |
2/13/2026
Event 12/31/2025
|
|||
| Hellman & Friedman Capital Partners X (Parallel), L.P. | 9.2% | ||||
| HFCP X (Parallel - A), L.P. | 1.0% | ||||
| Mend Partners II, L.P. | 0.5% | ||||
| Mend Investment Holdings I, L.P. | 12.5% | ||||
| Hellman & Friedman Investors X, L.P. | 23.2% | ||||
| Mend Partners GP, LLC | 0.5% | ||||
| Mend Investment Holdings GP, LLC | 12.5% | ||||
| Hellman & Friedman Capital Partners X, L.P. | 12.5% | ||||
| H&F Corporate Investors X, Ltd. | 23.2% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.